Watchlist Price Alert

PharmaCyte Biotech Inc. (PMCB)

NASDAQ: PMCB · Real-Time Price · USD

1.04

0.01 (0.97%)

At close: May 20, 2025, 3:59 PM

1.04

0.00%

After-hours: May 20, 2025, 07:31 PM EDT

PharmaCyte Biotech Income Statement

Financials in USD. Fiscal year is May - April.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020	Apr 30, 2019	Apr 30, 2018	Apr 30, 2017	Apr 30, 2016
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-6.52M	-6.46M	-4.39M	-3.62M	-3.83M	-4.1M	-6.98M	-4.44M	-6.07M
Interest Income	3.4M	1.94M	157.65K	3.05	0.45	n/a	n/a	n/a	n/a
Pretax Income	333.76K	-4.32M	-4.24M	-3.55M	-3.83M	-4.07M	-6.83M	-4.44M	-6.06M
Net Income	333.76K	-4.32M	-4.09M	-3.55M	-3.83M	-4.07M	-6.83M	-4.44M	-6.06M
Selling & General & Admin	2.12M	5.99M	3.7M	2.71M	3.53M	3.64M	4.98M	3.26M	4.67M
Research & Development	407.43K	468.54K	690.94K	916.25K	301.22K	460.05K	2M	1.18M	1.41M
Other Expenses	n/a	202K	-4.28K	-1.19K	-40	33.4K	152.59K	2.52M	10.54K
Operating Expenses	8.52M	6.46M	4.39M	3.62M	3.83M	4.1M	6.98M	4.44M	6.07M
Interest Expense	n/a	n/a	509.00	3.05K	453.00	n/a	n/a	1.54K	1.19K
Selling & Marketing Expenses	1.32M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	6.52M	6.46M	4.39M	3.62M	3.83M	4.1M	6.98M	4.44M	6.07M
Income Tax Expense	n/a	-1.94M	-153.36K	3.05K	453.00	-33.4K	-152.59K	-4.44K	-4.88K
Shares Outstanding (Basic)	9.58M	19.49M	15.52M	1.45M	903.81K	733.4K	645.76K	563.54K	501.6K
Shares Outstanding (Diluted)	9.58M	19.49M	15.52M	1.45M	903.81K	733.4K	646.08K	563.82K	501.85K
EPS (Basic)	-1.8	-0.22	-0.26	-2.46	-4.23	-5.55	-10.57	-7.89	-12.09
EPS (Diluted)	-1.8	-0.22	-0.26	-2.46	-4.23	-5.55	-10.57	-7.88	-12.08
EBITDA	n/a	n/a	n/a	n/a	-3.83M	n/a	n/a	-4.44M	n/a
EBIT	-6.52M	-6.46M	-4.24M	-3.55M	-3.83M	-4.07M	-6.83M	-4.44M	-6.06M
Depreciation & Amortization	n/a	6.46M	4.39M	3.62M	3.83M	4.1M	6.98M	4.44M	6.07M